AR044177A1 - Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinona - Google Patents

Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinona

Info

Publication number
AR044177A1
AR044177A1 ARP040101537A ARP040101537A AR044177A1 AR 044177 A1 AR044177 A1 AR 044177A1 AR P040101537 A ARP040101537 A AR P040101537A AR P040101537 A ARP040101537 A AR P040101537A AR 044177 A1 AR044177 A1 AR 044177A1
Authority
AR
Argentina
Prior art keywords
preparation
trans
derivatives
formula
lactone
Prior art date
Application number
ARP040101537A
Other languages
English (en)
Inventor
Kiran Kumar Ganagakhedkar Shubham Karooti
Parendu Dhirajlal Rathod
Yatendra Kumar
Ram Cahnder Aryan
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of AR044177A1 publication Critical patent/AR044177A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se refiere a los procesos para la preparación de trans-isómeros de derivados de la difenilazetidinona, utilizando una delta-lactona quiral. Asimismo se relaciona con los procesos para la preparación del delta-lactona quiral. Además se refiere a las composiciones farmacéuticas que incluyen los trans-isómeros de los derivados de la difenilazetidinona. Reivindicación 1: Un proceso para preparar transisómeros de la difenilazetidinona de la fórmula (1), como se muestra en los diseños que se acompañan, o una sal de los mismos, en donde R1 y R2 son idénticos o diferentes, y representan al hidrógeno, halógeno o a un grupo alcoxi, y R3 representa al hidrógeno, alquilo o a un grupo protector hidroxi, que comprende la reacción de una delta lactona quiral de la fórmula (2), como se muestra en los diseños que se acompañan, en donde R1 es lo que se ha definido precedentemente, con una difenil imina de la fórmula (3), en donde R2, y R3, son lo que se ha definido precedentemente, ante la presencia de una base fuerte.
ARP040101537A 2003-05-05 2004-05-06 Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinona AR044177A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN668DE2003 2003-05-05

Publications (1)

Publication Number Publication Date
AR044177A1 true AR044177A1 (es) 2005-08-24

Family

ID=33428285

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101537A AR044177A1 (es) 2003-05-05 2004-05-06 Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinona

Country Status (4)

Country Link
EP (1) EP1626954A2 (es)
CN (1) CN1805926A (es)
AR (1) AR044177A1 (es)
WO (1) WO2004099132A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
DE602004029715D1 (de) 2003-12-23 2010-12-02 Astrazeneca Ab Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
JP2007526251A (ja) * 2004-12-03 2007-09-13 テバ ファーマシューティカル インダストリーズ リミティド エゼチミベ多形体
TW200726746A (en) 2005-05-06 2007-07-16 Microbia Inc Processes for production of 4-biphenylylazetidin-2-ones
AU2006244043A1 (en) * 2005-05-11 2006-11-16 Microbia, Inc. Processes for production of phenolic 4-biphenylylazetidin-2-ones
US20090099355A1 (en) * 2005-05-25 2009-04-16 Microbia, Inc. Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR057072A1 (es) 2005-06-22 2007-11-14 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
WO2007017705A1 (en) * 2005-08-09 2007-02-15 Glenmark Pharmaceuticals Limited Process for the preparation of azetidinones
WO2008061238A2 (en) * 2006-11-16 2008-05-22 Ironwood Pharmaceuticals, Inc. Processes for production of 4-biphenylyazetidin-2-ones
EP2128133A1 (en) * 2008-05-26 2009-12-02 Lek Pharmaceuticals D.D. Ezetimibe process and composition
AU2009253877B2 (en) * 2008-06-02 2013-09-12 Cipla Limited Process for the synthesis of arformoterol
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
PL231215B1 (pl) 2011-06-15 2019-02-28 Inst Chemii Organicznej Polskiej Akademii Nauk Sposób wytwarzania podstawionych azetydynonów oraz związków pośrednich do ich syntezy
CN103086938A (zh) * 2011-10-28 2013-05-08 沈阳药科大学 依泽替米贝的合成方法
CN103121966A (zh) * 2011-11-17 2013-05-29 重庆华邦胜凯制药有限公司 定向合成(4-氯苯基)-(吡啶-2-基)-甲醇的方法
CN103204795B (zh) * 2012-01-11 2016-12-14 重庆华邦胜凯制药有限公司 一种手性氮杂环丁酮类化合物的制备方法
WO2013189646A1 (de) * 2012-06-22 2013-12-27 Henkel Ag & Co. Kgaa Photolabile duftspeicherstoffe
CN104744331B (zh) * 2013-12-31 2018-05-15 浙江九洲药业股份有限公司 一种依泽替米贝中间体的合成工艺
CN107176920B (zh) * 2017-04-19 2019-09-20 江苏恒盛药业有限公司 一种依泽麦布的合成新工艺
CN108586373A (zh) * 2018-06-22 2018-09-28 苏州市贝克生物科技有限公司 依折麦布中间体的合成方法
CN110818606B (zh) * 2018-08-08 2021-06-29 上海博志研新药物技术有限公司 依折麦布及其中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents

Also Published As

Publication number Publication date
EP1626954A2 (en) 2006-02-22
WO2004099132A2 (en) 2004-11-18
CN1805926A (zh) 2006-07-19
WO2004099132A3 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
AR044177A1 (es) Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinona
GT200300292A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal
CY1105162T1 (el) Ενωσεις και η χρηση τους ως αναστολεις 5-ητ
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE421322T1 (de) Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
BRPI0608604B8 (pt) moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
UY28333A1 (es) Inhibidores de caspasa y sus usos.
UY27803A1 (es) Derivados de benzoxazina y usos de los mismos.
BRPI0407695A (pt) compostos, processo para a preparação de um composto, composições farmacêuticas que compreendem o composto, utilização dos compostos e processo de tratamento para diabetes do tipo 2
BRPI0508102A (pt) inibidores de caspase e usos dos mesmos
AR041297A1 (es) Derivados de 4-pirrolidino- fenil- bencil eter
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
CY1108366T1 (el) Βενζοσουλφονικο αλας της 7-(2-(4-(3-τριφθορομεθυλ-φαινυλ-1,2,3,6-τετραϋδρο-πυριδ-1-υλ)αιθυλ)ισοκινολινης, η παρασκευη του και η χρηση του στη φαρμακευτικη αγωγη
AR074053A1 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), y composiciones farmaceuticas que los contienen
UY27716A1 (es) Derivados de nitrosodifenilamina y composiciones farmacéuticas que los comprenden como medicamentos que se pueden utilizar en el tratamiento de patologías que se caracterizan por estrés oxidativo.
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
NI200900147A (es) Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
PA8589801A1 (es) Aminoalcoxiindoles
ECSP088257A (es) Derivados de amida
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos

Legal Events

Date Code Title Description
FB Suspension of granting procedure